Please login to the form below

Not currently logged in
Email:
Password:

Abexinostat

This page shows the latest Abexinostat news and features for those working in and with pharma, biotech and healthcare.

Servier announces job cuts as pressures mount

Servier announces job cuts as pressures mount

Servier has also had some pipeline setbacks of late. Last year the company abandoned development of its HDAC inhibitor abexinostat for cancer, returning rights to Pharmacyclics, while in October it walked

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    And finally, Xynomic, the US/China biopharmaceutical company has picked up two products: ACAT-1 from the US company Resarci Therapeutics and abexinostat from a mystery seller who Xynomic declined to ... name. (Abexinostat was formerly in development by

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics